Literature DB >> 19191307

Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database.

Robert G Miller1, Fred Anderson, Benjamin Rix Brooks, Hiroshi Mitsumoto, Walter G Bradley, Steven P Ringel.   

Abstract

OBJECTIVE: To examine the care of patients with ALS following the publication of the standardized recommendations for the management of patients with amyotrophic lateral sclerosis (ALS) published in 1999 by the American Academy of Neurology.
METHODS: Specific aspects of ALS patient management have been evaluated serially using a national Amyotrophic Lateral Sclerosis Clinical Assessment, Research, and Education (ALS CARE) database to encourage compliance with these recommendations and to assure continuing quality improvement.
RESULTS: The most recent analysis of 5,600 patients shows interesting epidemiological observations and treatment trends. Proper management of many ALS symptoms has increased substantially since the first publication of the guidelines, and awareness of pseudobulbar affect has increased. Other recommendations are underutilized: Only 9% undergo percutaneous endoscopic gastrostomy, although this procedure was recommended in 22% of patients; and noninvasive positive pressure ventilation was used by only 21% of patients despite being associated with improved 5-year survival rates.
INTERPRETATION: This observational database has been a useful tool in monitoring compliance with the standard of care for patients with ALS and may have resulted in greater adherence to guidelines.

Entities:  

Mesh:

Year:  2009        PMID: 19191307     DOI: 10.1002/ana.21556

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  15 in total

1.  Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm.

Authors:  Paul Wicks; Timothy E Vaughan; Michael P Massagli; James Heywood
Journal:  Nat Biotechnol       Date:  2011-04-24       Impact factor: 54.908

2.  Predictors of emergent feeding tubes and tracheostomies in amyotrophic lateral sclerosis (ALS).

Authors:  Amy Y Tsou; Jason Karlawish; Leo McCluskey; Sharon X Xie; Judith A Long
Journal:  Amyotroph Lateral Scler       Date:  2012-05

Review 3.  Quo vadis motor neuron disease?

Authors:  Rubika Balendra; Rickie Patani
Journal:  World J Methodol       Date:  2016-03-26

4.  Brain-computer interface (BCI) evaluation in people with amyotrophic lateral sclerosis.

Authors:  Lynn M McCane; Eric W Sellers; Dennis J McFarland; Joseph N Mak; C Steve Carmack; Debra Zeitlin; Jonathan R Wolpaw; Theresa M Vaughan
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-02-20       Impact factor: 4.092

5.  Role of VEGF and VEGFR2 Receptor in Reversal of ALS-CSF Induced Degeneration of NSC-34 Motor Neuron Cell Line.

Authors:  K Vijayalakshmi; Piyush Ostwal; R Sumitha; S Shruthi; Anu Mary Varghese; Poojashree Mishra; S Gowri Manohari; B C Sagar; T N Sathyaprabha; A Nalini; T R Raju; Phalguni Anand Alladi
Journal:  Mol Neurobiol       Date:  2014-06-01       Impact factor: 5.590

Review 6.  Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of Neurology.

Authors:  Robert G Miller; Benjamin Rix Brooks; Rebecca J Swain-Eng; Robert C Basner; Gregory T Carter; Patricia Casey; Adam B Cohen; Richard Dubinsky; Dallas Forshew; Carlayne E Jackson; Ed Kasarskis; Nicholas J Procaccini; Mohammed Sanjak; Fredrik P Tolin
Journal:  Neurology       Date:  2013-11-22       Impact factor: 9.910

7.  Sharing health data for better outcomes on PatientsLikeMe.

Authors:  Paul Wicks; Michael Massagli; Jeana Frost; Catherine Brownstein; Sally Okun; Timothy Vaughan; Richard Bradley; James Heywood
Journal:  J Med Internet Res       Date:  2010-06-14       Impact factor: 5.428

8.  Current status of the diagnosis and management of amyotrophic lateral sclerosis in Korea: a multi-center cross-sectional study.

Authors:  Jong Seok Bae; Yoon-Ho Hong; Wonki Baek; Eun Hee Sohn; Joong-Yang Cho; Byung-Jo Kim; Seung Hyun Kim
Journal:  J Clin Neurol       Date:  2012-12-21       Impact factor: 3.077

9.  Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients.

Authors:  Pooja-Shree Mishra; Dinesh K Dhull; A Nalini; K Vijayalakshmi; T N Sathyaprabha; Phalguni Anand Alladi; Trichur R Raju
Journal:  J Neuroinflammation       Date:  2016-08-30       Impact factor: 8.322

10.  Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.

Authors:  Paul Talman; Thi Duong; Steve Vucic; Susan Mathers; Svetha Venkatesh; Robert Henderson; Dominic Rowe; David Schultz; Robert Edis; Merrilee Needham; Richard Macdonnell; Pamela McCombe; Carol Birks; Matthew Kiernan
Journal:  BMJ Open       Date:  2016-09-30       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.